Is SBBP or BTI a better dividend investment in 2026?

SBBP currently yields 100.00% with a 5% 5-year dividend growth rate. BTI yields 5.40% with 5% growth. The better choice depends on your goal: SBBP offers higher current income.

What is the dividend yield difference between SBBP and BTI?

SBBP has a forward dividend yield of 100.00% ($2.00/share annually). BTI yields 5.40% ($3.15/share annually). The yield gap is 94.60 percentage points.

Home › Compare › SBBP vs BTI

SBBP vs BTI: Dividend Comparison 2026

SBBP yields 100.00% · BTI yields 5.40%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SBBP wins by $3.86M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SBBP

● Live price

100.00%

Share price

$2.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3.90M

Annual income

$1,312,946.05

Full SBBP calculator →

BTI

● Live price

5.40%

Share price

$58.26

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.8K

Annual income

$2,802.29

Full BTI calculator →

Portfolio growth — SBBP vs BTI

📍 SBBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SBBP	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SBBP + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SBBP pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBBP

Annual income on $10K today (after 15% tax)

$8,500.00/yr

After 10yr DRIP, annual income (after tax)

$1,116,004.14/yr

BTI

Annual income on $10K today (after 15% tax)

$459.05/yr

After 10yr DRIP, annual income (after tax)

$2,381.95/yr

At 15% tax rate, SBBP beats the other by $1,113,622.20/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBBP + BTI for your $10,000?

SBBP: 50%BTI: 50%

100% BTI50/50100% SBBP

Portfolio after 10yr

$1.97M

Annual income

$657,874.16/yr

Blended yield

33.45%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

SBBP

Analyst Ratings

Buy

Hold

Consensus: Buy

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.3% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBBP buys

BTI buys

No recent congressional trades found for SBBP or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSBBPBTI

Forward yield	100.00% ✓	5.40%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$3.90M	$37.8K ✓
Annual income after 10y	$1,312,946.05 ✓	$2,802.29
Total dividends collected	$3.48M	$14.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Buy	Buy

Year-by-year: SBBP vs BTI ($10,000, DRIP)

Year	SBBP Portfolio	SBBP Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$20,700	$10,000.00	$11,301	$601.08	+$9.4K → SBBP
2	$41,495	$19,345.79	$12,799	$706.58	+$28.7K → SBBP
3	$80,643	$36,243.16	$14,527	$832.38	+$66.1K → SBBP
4	$152,116	$65,828.38	$16,527	$982.75	+$135.6K → SBBP
5	$278,813	$116,048.53	$18,846	$1,162.95	+$260.0K → SBBP
6	$497,119	$198,789.52	$21,545	$1,379.49	+$475.6K → SBBP
7	$863,169	$331,251.38	$24,694	$1,640.41	+$838.5K → SBBP
8	$1,461,129	$537,538.09	$28,378	$1,955.69	+$1.43M → SBBP
9	$2,413,798	$850,390.15	$32,702	$2,337.79	+$2.38M → SBBP
10	$3,895,710	$1,312,946.05	$37,794	$2,802.29	+$3.86M → SBBP

SBBP vs BTI: Complete Analysis 2026

SBBP — Stock

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.

Full SBBP Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this SBBP vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBBP vs SCHD SBBP vs JEPI SBBP vs O SBBP vs KO SBBP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.